Rationale and Design of the PRegnancy and Infant DEvelopment (PRIDE) Study
Article first published online: 5 DEC 2012
© 2012 Blackwell Publishing Ltd
Paediatric and Perinatal Epidemiology
Volume 27, Issue 1, pages 34–43, January 2013
How to Cite
van Gelder, M. M. H. J., Bretveld, R. W., Roukema, J., Steenhoek, M., van Drongelen, J., Spaanderman, M. E. A., van Rumpt, D., Zielhuis, G. A., Verhaak, C. M. and Roeleveld, N. (2013), Rationale and Design of the PRegnancy and Infant DEvelopment (PRIDE) Study. Paediatric and Perinatal Epidemiology, 27: 34–43. doi: 10.1111/ppe.12023
- Issue published online: 5 DEC 2012
- Article first published online: 5 DEC 2012
- 2008 Investment Fund Grant. Grant Number: 3.4.10.007
- Radboud University Nijmegen Medical Centre
- Netherlands Asthma Foundation
- Netherlands Organisation for Scientific Research. Grant Number: NWO; grant no. 021.001.008
- PRIDE Study;
- attention-deficit/hyperactivity disorder;
To optimise the health of pregnant women and their children by evidence-based primary and secondary prevention, more scientific knowledge is needed. To overcome the methodological limitations of many studies on pregnancy and child health, which often use a retrospective design, we established the PRIDE (PRegnancy and Infant DEvelopment) Study.
Methods and Results
The PRIDE Study is a large prospective cohort study that aims at including 150 000–200 000 women in early pregnancy to study a broad range of research questions pertaining to pregnancy complications, maternal and child health, and adverse developmental effects in offspring. Women are invited to participate by their prenatal care provider before or at their first prenatal care visit and are asked to fill out web-based questionnaires in gestational weeks 8–10, 17, and 34, as well as biannually throughout childhood. In addition, a food frequency questionnaire and a paternal questionnaire are administered and medical records are consulted. Multiple validation studies will be conducted and paper-and-pencil questionnaires are available for women who cannot or do not want to participate through the Internet. For subgroups of participants, blood and saliva samples for genetic and biochemical analyses are being collected. The pilot phase, which started in July 2011, showed a response rate of 47%. Recruitment will eventually cover all of the Netherlands.
We expect that this study, which will be the largest birth cohort in the world so far, will provide new insights in the aetiology of disorders and diseases that originate in pregnancy. The PRIDE Study is open for collaboration.